Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Please select the quantity
CAS RN: 80214-83-1 | Product Number: R0164
Roxithromycin
Purity: >95.0%(HPLC)
Synonyms:
- Erythromycin 9-[O-(2-Methoxyethoxy)methyloxime]
Product Documents:
Size | Unit Price | Belgium | Japan* |
---|---|---|---|
5G |
€44.00
|
2 | 11 |
25G |
€142.00
|
1 | 20 |
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Product Number | R0164 |
Purity / Analysis Method | >95.0%(HPLC) |
Molecular Formula / Molecular Weight | C__4__1H__7__6N__2O__1__5 = 837.06 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 80214-83-1 |
Reaxys Registry Number | 5900029 |
PubChem Substance ID | 253661176 |
Merck Index (14) | 8276 |
MDL Number | MFCD00214389 |
Specifications
Appearance | White to Almost white powder to crystal |
Purity(HPLC) | min. 95.0 area% |
Elemental analysis(Nitrogen) | 3.10 to 3.60 % |
Specific rotation [a]20/D | -93.0 to -96.0 deg(C=1, Acetone)(calcd.on anh.substance) |
Water | max. 3.0 % |
Properties (reference)
Melting Point | 120 °C |
Specific Rotation | -95° (C=1,Acetone) |
Solubility (soluble in) | Methanol |
GHS
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. |
Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
RTECS# | KF4990000 |
Transport Information:
HS Number | 2941500000 |
Application
Roxithromycin: An Acid-Stable and Enteric Absorbent Semi-Synthetic Macrolide Antibiotic
Macrolide antibiotics are classified by the size of the macrocyclic lactone ring of aglycone as 14-, 15- or 16-membered ring macrolides. Macrolides are characterized by similar chemical structures, mechanisms of action and resistance, but vary in the different pharmacokinetic parameters, and spectrum of activity. Roxithromycin (abbrev: RXM) is chemically synthesized from erythromycin [E0751] to create a more acid-stable antimicrobial and prevents the degradation of the erythromycin base to the hemiketal intermediate. RXM has an in vitro antibacterial profile similar to that of erythromycin. RXM has a pharmacokinetic profile that is characterized by excellent enteric absorption within macrolide antibiotics achieving high concentrations in most tissues and body fluids. In addition, RXM immunomodulatory activities have reported.
References
- A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy
- The new macrolide antibiotics: azithromycin, clarithromycin, dirithromycin, and roxithromycin (a review)
- Roxithromycin: review of its antimicrobial activity
- Analysis of macrolide antibiotics (a review)
- Determination of erythromycin, clarithromycin, roxithromycin, and azithromycin in plasma by high-performance liquidchromatography with amperometric detection
- Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.